Sanguedolce, F.; Zanelli, M.; Palicelli, A.; Ascani, S.; Zizzo, M.; Cocco, G.; Björnebo, L.; Lantz, A.; Landriscina, M.; Conteduca, V.;
et al. Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation. Int. J. Mol. Sci. 2022, 23, 7844.
https://doi.org/10.3390/ijms23147844
AMA Style
Sanguedolce F, Zanelli M, Palicelli A, Ascani S, Zizzo M, Cocco G, Björnebo L, Lantz A, Landriscina M, Conteduca V,
et al. Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation. International Journal of Molecular Sciences. 2022; 23(14):7844.
https://doi.org/10.3390/ijms23147844
Chicago/Turabian Style
Sanguedolce, Francesca, Magda Zanelli, Andrea Palicelli, Stefano Ascani, Maurizio Zizzo, Giorgia Cocco, Lars Björnebo, Anna Lantz, Matteo Landriscina, Vincenza Conteduca,
and et al. 2022. "Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation" International Journal of Molecular Sciences 23, no. 14: 7844.
https://doi.org/10.3390/ijms23147844
APA Style
Sanguedolce, F., Zanelli, M., Palicelli, A., Ascani, S., Zizzo, M., Cocco, G., Björnebo, L., Lantz, A., Landriscina, M., Conteduca, V., Falagario, U. G., Cormio, L., & Carrieri, G.
(2022). Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation. International Journal of Molecular Sciences, 23(14), 7844.
https://doi.org/10.3390/ijms23147844
